4//SEC Filing
BONE CARE INTERNATIONAL INC 4
Accession 0001209191-05-034825
CIK 0001009405operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:10 AM ET
Size
7.8 KB
Accession
0001209191-05-034825
Insider Transaction Report
Form 4
Bishop Charles W
EVP - Chief Scientific Officer
Transactions
- Disposition to Issuer
BCII Common Stock
2005-07-01$33.00/sh−100,000$3,300,000→ 0 total - Exercise/Conversion
BCII Stock Option Plan
2005-07-01$8.47/sh−100,000$847,000→ 0 totalExercise: $24.53Exp: 2015-04-25→ BCII Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.
Documents
Issuer
BONE CARE INTERNATIONAL INC
CIK 0001009405
Entity typeoperating
IncorporatedWI
Related Parties
1- filerCIK 0001009405
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:10 AM ET
- Size
- 7.8 KB